SOPHiA GENETICS (SOPH) Operating Expenses (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Operating Expenses data on file, last reported at -$23.3 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 12.77% year-over-year to -$23.3 million; the trailing twelve-month figure through Dec 2025 stood at -$86.8 million (down 8.23% YoY), and the FY2025 full-year result was -$86.8 million, down 13.08% from the prior year.
• Operating Expenses retreated to -$23.3 million in Q4 2025, from -$22.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$14.6 million in Q2 2021 to a low of -$23.9 million in Q1 2022.
• A 5-year average of -$20.8 million and a median of -$21.3 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 99.8% in 2021 and plunged 62.14% in 2022, its largest moves.
• Tracing SOPH's Operating Expenses over 5 years: stood at -$19.3 million in 2021, then slipped by 7.26% to -$20.7 million in 2022, then declined by 5.5% to -$21.9 million in 2023, then climbed by 5.43% to -$20.7 million in 2024, then decreased by 12.77% to -$23.3 million in 2025.
• Business Quant data shows SOPH's Operating Expenses at -$23.3 million in Q4 2025, -$22.0 million in Q3 2025, and -$20.8 million in Q2 2025.